<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03441620</url>
  </required_header>
  <id_info>
    <org_study_id>1119274</org_study_id>
    <nct_id>NCT03441620</nct_id>
  </id_info>
  <brief_title>The Effects of Strawberries on Blood Cholesterol.</brief_title>
  <official_title>Effects of Strawberries on LDL Cholesterol and Insulin Resistance in Overweight/Obese Adults With the Metabolic Syndrome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nevada, Las Vegas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oklahoma State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Nevada, Las Vegas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we propose to investigate the effects of dietary achievable doses of&#xD;
      strawberries on serum LDL-cholesterol (LDL-C) and related lipid profiles, measures of&#xD;
      glycemia and insulin resistance, and biomarkers of inflammation in a 14 week controlled&#xD;
      crossover study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The screen visit will involve an 8 hour fasting state and the following procedures:&#xD;
&#xD;
        -  Completing screening questionnaire&#xD;
&#xD;
        -  Measuring height, weight, blood pressure, and waist size&#xD;
&#xD;
        -  Drawing about 30mL blood for blood glucose and lipids and comprehensive metabolic panel&#xD;
           All subjects will be asked to follow usual diet and lifestyle, and refrain from other&#xD;
           sources of berries and related products while on the study. Subjects will also maintain&#xD;
           3-day food records at screen, 4, 9, and 14 weeks of the study. Height, weight, blood&#xD;
           pressure and waist circumference will be measured by trained personnel at MPE 326 (KNS&#xD;
           facility for clinical research). Blood draws will be performed by trained phlebotomists&#xD;
           (to be hired) at MPE 326, and all procedures will be performed by trained research&#xD;
           personnel [PI &amp;Co-PI: Basu, Izuora and graduate student]. In case of blood pressure, an&#xD;
           average of at least three readings, 10 min apart, will be measured at each visit for&#xD;
           each participant. Blood glucose (fasting and postprandial at two hours) will be&#xD;
           determined at each time point. The oral glucose tolerance tests will be conducted at MPE&#xD;
           326 and blood samples will be sent to Quest Diagnostics, Las Vegas. Insulin resistance&#xD;
           will be calculated using the homoeostatic model assessment (HOMA-IR). The HOMA-IR is a&#xD;
           standard and widely used formula in calculating insulin resistance based on fasting&#xD;
           glucose values. Screening and follow-up tests will include clinical laboratory tests for&#xD;
           blood glucose, lipids, NMR profiles, C-reactive protein and metabolic panel to determine&#xD;
           effects of the intervention.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Actual">January 31, 2021</completion_date>
  <primary_completion_date type="Actual">January 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum Lipid profiles</measure>
    <time_frame>14 weeks</time_frame>
    <description>Serum LDL, total and HDL cholesterol, triglycerides</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glycemic control</measure>
    <time_frame>14 weeks</time_frame>
    <description>Blood glucose</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum lipid particle concentrations</measure>
    <time_frame>14 weeks</time_frame>
    <description>Molar concentrations of serum lipids and particle size</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diabetes control</measure>
    <time_frame>14 weeks</time_frame>
    <description>Insulin resistance</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systemic Inflammation</measure>
    <time_frame>14 weeks</time_frame>
    <description>Serum C-reactive protein and adipokines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systemic Anthocyanins</measure>
    <time_frame>14 weeks</time_frame>
    <description>Strawberry anthocyanin metabolites measured in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum metabolomics</measure>
    <time_frame>14 weeks</time_frame>
    <description>primary and lipid metabolites in serum</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Hyper-LDL-cholesterolemia</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Calorie and fiber-matched control powder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Strawberry one serving</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Freeze-dried powder equivalent to one serving fresh strawberries per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Strawberry two-half servings</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Freeze-dried powder equivalent to 2.5 serving fresh strawberries per day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>strawberries</intervention_name>
    <description>Freeze-dried strawberry powder</description>
    <arm_group_label>Strawberry one serving</arm_group_label>
    <arm_group_label>Strawberry two-half servings</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control powder</intervention_name>
    <description>Control powder matched for fiber and strawberries</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  elevated total and LDL cholesterol (&gt;116 mg/dL)&#xD;
&#xD;
          -  body mass index (&gt; or = 30 kg/m2)&#xD;
&#xD;
          -  features of the metabolic syndrome&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  taking glucose and lipid lowering medications (e.g. statins, metformin)&#xD;
&#xD;
          -  history of chronic conditions (diabetes, CHD, anemia, renal diseases)&#xD;
&#xD;
          -  allergic to strawberries&#xD;
&#xD;
          -  pregnant and/or lactating&#xD;
&#xD;
          -  smoking&#xD;
&#xD;
          -  vegetarian or consuming special diet&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arpita Basu, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nevada at Las Vegas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Nevada at Las Vegas</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89154</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center, OCTSI</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oklahoma State University</name>
      <address>
        <city>Stillwater</city>
        <state>Oklahoma</state>
        <zip>74078</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 5, 2018</study_first_submitted>
  <study_first_submitted_qc>February 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 22, 2018</study_first_posted>
  <last_update_submitted>March 12, 2021</last_update_submitted>
  <last_update_submitted_qc>March 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nevada, Las Vegas</investigator_affiliation>
    <investigator_full_name>Arpita Basu</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

